The activation of Snail in a considerable subset of human PNETs and the successful effect of Snail inhibition by PEG in islet cell tumors of transgenic mice provides first evidence of Snail as a drug target in PNET. This evidence concerns the gene SNAI1 and primitive neuroectodermal tumor.